We investigated how the non-medical switching (NMS) between Etanercept (ETN)/originator and SB4/biosimilar affects treatment efficacy in a rheumatic disease (RD) cohort, evaluating some laboratory parameters as loss of efficacy predictors after NMS.

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease / Benucci, Maurizio; Damiani, Arianna; Russo, Edda; Li Gobbi, Francesca; Grossi, Valentina; Amedei, Amedeo; Infantino, Maria; Manfredi, Mariangela. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - ELETTRONICO. - 12:(2022), pp. 1174-1184. [10.3390/jpm12071174]

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease

Damiani, Arianna;Russo, Edda;Amedei, Amedeo;
2022

Abstract

We investigated how the non-medical switching (NMS) between Etanercept (ETN)/originator and SB4/biosimilar affects treatment efficacy in a rheumatic disease (RD) cohort, evaluating some laboratory parameters as loss of efficacy predictors after NMS.
12
1174
1184
Benucci, Maurizio; Damiani, Arianna; Russo, Edda; Li Gobbi, Francesca; Grossi, Valentina; Amedei, Amedeo; Infantino, Maria; Manfredi, Mariangela
File in questo prodotto:
File Dimensione Formato  
jpm-12-01174.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 1.04 MB
Formato Adobe PDF
1.04 MB Adobe PDF Visualizza/Apri

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/1286760
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact